| Solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects S Scioli Montoto, G Muraca, ME Ruiz Frontiers in molecular biosciences 7, 319, 2020 | 373 | 2020 |
| The Pseudomonas aeruginosa biofilm matrix and cells are drastically impacted by gas discharge plasma treatment: A comprehensive model explaining plasma … J Soler-Arango, C Figoli, G Muraca, A Bosch, G Brelles-Marino PLoS One 14 (6), e0216817, 2019 | 50 | 2019 |
| Improving ciprofloxacin antimicrobial activity through lipid nanoencapsulation or non-thermal plasma on Pseudomonas aeruginosa biofilms GS Muraca, J Soler-Arango, GR Castro, GA Islan, G Brelles-Marino Journal of Drug Delivery Science and Technology 64, 102644, 2021 | 13 | 2021 |
| Trypanosomatid-caused conditions: state of the art of therapeutics and potential applications of lipid-based nanocarriers G Muraca, IR Berti, ML Sbaraglini, WJ Fávaro, N Durán, GR Castro, ... Frontiers in Chemistry 8, 601151, 2020 | 11 | 2020 |
| Preparation, physicochemical and biopharmaceutical characterization of oxcarbazepine-loaded nanostructured lipid carriers as potential antiepileptic devices SS Montoto, G Muraca, M Di Ianni, M Couyoupetrou, G Pesce, GA Islan, ... Journal of Drug Delivery Science and Technology 63, 102470, 2021 | 8 | 2021 |
| Solid lipid nanoparticles for drug delivery: Pharmacological and biopharmaceutical aspects. Front Mol Biosci 2020; 7: 587997 S Scioli Montoto, G Muraca, ME Ruiz | 6 | 2020 |
| Solid Lipid Nanoparticles for drug delivery: Pharmacological and biopharmaceutical aspects. Frontiers in Molecular Biosciences 7: 587997 S Scioli Montoto, G Muraca, ME Ruiz | 4 | 2020 |
| Solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects, Front. Mol. Biosci. 7 (2020) SS Montoto, G Muraca, ME Ruiz | 4 | 2020 |
| Nanostructured lipid carriers containing benznidazole: physicochemical, biopharmaceutical and cellular in vitro studies G Muraca, ME Ruiz, RC Gambaro, S Scioli-Montoto, ML Sbaraglini, ... Beilstein Journal of Nanotechnology 14 (1), 804-818, 2023 | 2 | 2023 |
| ENFERMEDAD DE CHAGAS: NOVEDADES EN NANOMEDICINAS COMO ESTRATEGIA TERAPÉUTICA GS Muraca, A Talevi, GO Pesce Revista Ciencia Reguladora 5, 32-37, 2019 | 1 | 2019 |
| When nanomedicines meet tropical diseases K Van Bocxlaer, G Muraca, ME Ruiz, RC Gambaro, S Scioli-Montoto, ... | | |
| ENFERMEDAD DE CHAGAS: DESARROLLO DE NANOVEHÍCULOS FARMACÉUTICOS ENCAPSULANDO BENZNIDAZOL GS Muraca, GA Islan, M Ruiz, S Scioli Montoto, GO Pesce, A Talevi | | |
